C50.919
BillableMalignant neoplasm of unsp site of unspecified female breast
Malignant neoplasm of unspecified site of unspecified female breast
Coding Notes
Includes
Conditions included under this code
- connective tissue of breast
- Paget's disease of breast
- Paget's disease of nipple
Excludes 1
Codes that cannot be used together with this code (mutual exclusion)
Use Additional Code
Additional codes that should follow this code
Related Codes(2)
Also Known As / Clinical Terms(242)
SNOMED CT
- Malignant melanoma of breast188050009
- Breast cancer254837009
- Malignant neoplasm of breast254837009
- Malignant tumor of breast254837009
- Malignant tumour of breast254837009
- CA - Carcinoma of breast254838004
- Carcinoma of breast254838004
- Scirrhous carcinoma of breast254839007
- Inflammatory carcinoma of breast254840009
- Mastitis carcinomatosa254840009
- Familial cancer of breast254843006
- Malignant cystosarcoma phyllodes of breast254844000
- Malignant phyllodes tumor of breast254844000
- Malignant phyllodes tumour of breast254844000
- Carcinoma of bone, connective tissue, skin and breast255068000
- Malignant neoplasm of bone, connective tissue, skin and breast271467005
- Sarcoma of breast278050001
- Infiltrating lobular carcinoma of breast278054005
- Lobular carcinoma of breast278054005
- Local recurrence of malignant neoplasm of breast314955001
- Local recurrence of malignant tumor of breast314955001
- Local recurrence of malignant tumour of breast314955001
- Primary malignant neoplasm of breast372137005
- Blood/lymphatic vessel invasion by tumor absent (breast)373401001
- Blood/lymphatic vessel invasion by tumour absent (breast)373401001
- Blood/lymphatic vessel invasion by tumor present (breast)373402008
- Blood/lymphatic vessel invasion by tumour present (breast)373402008
- Blood/lymphatic vessel invasion by tumor indeterminate (breast)373403003
- Blood/lymphatic vessel invasion by tumour indeterminate (breast)373403003
- Anaplastic syringoma403939009
- Carcinoma simplex403939009
- Eccrine ductal carcinoma403939009
- Eccrine ductal carcinoma of skin403939009
- Malignant acrospiroma403939009
- Malignant eccrine acrospiroma403939009
- Infiltrating duct carcinoma of breast408643008
- Infiltrating ductal carcinoma of breast408643008
- Invasive duct carcinoma of breast408643008
- Invasive ductal carcinoma of breast408643008
- Hormone receptor positive malignant neoplasm of breast417181009
- Hormone receptor positive tumor417742002
- Hormone receptor positive tumour417742002
- Infiltrating ductal carcinoma of breast, stage 1422399001
- Infiltrating ductal carcinoma of breast, stage 2422479008
- Infiltrating ductal carcinoma of breast, stage 3423114009
- Infiltrating ductal carcinoma of breast, stage 4424229006
- HER2-positive carcinoma of breast427685000
- Human epidermal growth factor 2 positive carcinoma of breast427685000
- Human epidermal growth factor 2 (HER2) negative carcinoma of breast431396003
- Human epidermal growth factor 2 negative carcinoma of breast431396003
- Hormone receptor negative neoplasm438628005
- Carcinoma of breast with ductal and lobular features444604002
- Mixed ductal and lobular carcinoma of breast444604002
- Mucinous carcinoma of breast444712000
- TNBC - Triple-negative breast cancer706970001
- Triple negative malignant neoplasm of breast706970001
- Triple-negative breast cancer706970001
- Phyllodes tumor of breast712989008
- Phyllodes tumour of breast712989008
- Invasive carcinoma of breast713609000
- Carcinoma of salivary gland type of breast716593008
- Salivary gland type cancer of breast716593008
- Hereditary breast and ovarian cancer syndrome718220008
- Primary angiosarcoma of breast721576006
- Primary intracystic papillary carcinoma of breast721595004
- Primary invasive pleomorphic lobular carcinoma of breast722524005
- Primary solid papillary carcinoma with invasion of breast722832009
- Metaplastic carcinoma of breast763479005
- Germline BRCA-mutated human epidermal growth factor receptor 2 negative metastatic carcinoma of breast767444009
- Germline BRCA-mutated, HER2-negative metastatic breast cancer767444009
- gBRCA-mutated, HER2(-) metastatic breast carcinoma767444009
- Adenocarcinoma of breast865954003
- Familial cancer of ovary1196879002
- Familial malignant neoplasm of ovary1196879002
- Familial ovarian cancer1196879002
- Primary infiltrating lobular carcinoma of breast1259322009
- Primary lobular carcinoma of breast1259322009
- Primary scirrhous carcinoma of breast1259383002
- Primary mucinous carcinoma of breast1259442004
- Primary carcinoma of breast with ductal and lobular features1259443009
- Primary mixed ductal and lobular carcinoma of breast1259443009
- Primary infiltrating duct carcinoma of breast1259590008
- Primary infiltrating ductal carcinoma of breast1259590008
- Primary invasive duct carcinoma of breast1259590008
- Primary invasive ductal carcinoma of breast1259590008
- Primary malignant cystosarcoma phyllodes of breast1259728006
- Primary malignant phyllodes tumor of breast1259728006
- Primary malignant phyllodes tumour of breast1259728006
- Metastatic carcinoma of breast1264495000
- Metastatic carcinoma to breast1264495000
- Secondary carcinoma of breast1264495000
- Primary metaplastic carcinoma of breast1268539002
- Breast cancer in partial remission1281812003
- Malignant neoplasm of breast in partial remission1281812003
- Metastatic lobular carcinoma1290700004
- Hidradenocarcinoma1293105001
- Primary carcinoma of breast1306293004
- Malignant neoplasm of ectopic site of breast1306294005
- Neoplasm of ectopic site of breast1306313002
- Primary malignant neoplasm of ectopic site of breast1306325004
- Primary inflammatory carcinoma of breast1306512006
- Recurrent primary malignant neoplasm of breast1306515008
- Breast cancer in complete remission44721000087109
- Breast cancer in full remission44721000087109
- Malignant neoplasm of breast in full remission44721000087109
- Breast cancer in remission45061000087102
- Malignant neoplasm of breast in remission45061000087102
- Cancer in complete remission550991000124107
- Cancer in full remission550991000124107
- Malignant neoplasm in complete remission550991000124107
- Malignant neoplasm in full remission550991000124107
- Cancer in partial remission551001000124108
- Malignant neoplasm in partial remission551001000124108
- HER2 positive metastatic breast cancer459391000124109
- Metastasis from human epidermal growth factor 2 positive carcinoma of breast459391000124109
- Metastatic human epidermal growth factor 2 positive carcinoma of breast459391000124109
- LABC - locally advanced breast cancer1082701000112100
- Locally advanced breast cancer1082701000112100
- Primary angiosarcoma of thorax682411000119106
- Primary angiosarcoma of trunk682421000119104
UMLS
Clinical Terms
- Breast cancer in complete remission
- Triple-negative breast cancer
- Local recurrence of malignant tumour of breast
- gBRCA-mutated, HER2(-) metastatic breast carcinoma
- Infiltrating ductal carcinoma of breast, stage 1
- Primary invasive pleomorphic lobular carcinoma of breast
- Blood/lymphatic vessel invasion by tumor absent (breast)
- Infiltrating ductal carcinoma of breast, stage 4
- Phyllodes tumor of breast
- Mucinous carcinoma of breast
- CA - Carcinoma of breast
- Mixed ductal and lobular carcinoma of breast
- Breast cancer in remission
- Cancer in partial remission
- Primary invasive duct carcinoma of breast
- Blood/lymphatic vessel invasion by tumour indeterminate (breast)
- Malignant neoplasm in complete remission
- Carcinoma simplex
- Invasive duct carcinoma of breast
- Malignant neoplasm in partial remission
- Carcinoma of breast with ductal and lobular features
- Sarcoma of breast
- Breast cancer in full remission
- Invasive carcinoma of breast
- Blood/lymphatic vessel invasion by tumour present (breast)
- Infiltrating ductal carcinoma of breast, stage 2
- Primary scirrhous carcinoma of breast
- Malignant cystosarcoma phyllodes of breast
- Human epidermal growth factor 2 positive carcinoma of breast
- Anaplastic syringoma
- LABC - locally advanced breast cancer
- Cancer in full remission
- Metastasis from human epidermal growth factor 2 positive carcinoma of breast
- Familial cancer of breast
- Carcinoma of breast
- Primary malignant phyllodes tumour of breast
- Malignant tumor of breast
- Adenocarcinoma of breast
- Carcinoma of bone, connective tissue, skin and breast
- Eccrine ductal carcinoma of skin
- Primary metaplastic carcinoma of breast
- Breast cancer
- Malignant neoplasm of breast in remission
- Lobular carcinoma of breast
- Primary lobular carcinoma of breast
- Infiltrating duct carcinoma of breast
- Scirrhous carcinoma of breast
- Metastatic carcinoma of breast
- Blood/lymphatic vessel invasion by tumor present (breast)
- Germline BRCA-mutated, HER2-negative metastatic breast cancer
- Familial ovarian cancer
- Metaplastic carcinoma of breast
- Local recurrence of malignant neoplasm of breast
- Primary infiltrating lobular carcinoma of breast
- Primary mucinous carcinoma of breast
- Primary infiltrating duct carcinoma of breast
- Primary malignant phyllodes tumor of breast
- Primary invasive ductal carcinoma of breast
- Malignant tumour of breast
- Malignant phyllodes tumour of breast
- Infiltrating lobular carcinoma of breast
- Metastatic human epidermal growth factor 2 positive carcinoma of breast
- Malignant phyllodes tumor of breast
- Malignant melanoma of breast
- Malignant neoplasm in full remission
- Metastatic carcinoma to breast
- Cancer in complete remission
- Mastitis carcinomatosa
- Phyllodes tumour of breast
- Primary carcinoma of breast with ductal and lobular features
- Hereditary breast and ovarian cancer syndrome
- Primary malignant cystosarcoma phyllodes of breast
- Primary solid papillary carcinoma with invasion of breast
- Eccrine ductal carcinoma
- Primary malignant neoplasm of breast
- Hormone receptor positive tumor
- Malignant acrospiroma
- Local recurrence of malignant tumor of breast
- Salivary gland type cancer of breast
- Primary mixed ductal and lobular carcinoma of breast
- Blood/lymphatic vessel invasion by tumor indeterminate (breast)
- Metastatic lobular carcinoma
- Locally advanced breast cancer
- Carcinoma of salivary gland type of breast
- Hormone receptor positive malignant neoplasm of breast
- Breast cancer in partial remission
- Hormone receptor positive tumour
- Triple negative malignant neoplasm of breast
- Primary malignant neoplasm of ectopic site of breast
- TNBC - Triple-negative breast cancer
- Human epidermal growth factor 2 (HER2) negative carcinoma of breast
- Hormone receptor negative neoplasm
- Neoplasm of ectopic site of breast
- Malignant neoplasm of ectopic site of breast
- Primary intracystic papillary carcinoma of breast
- Primary inflammatory carcinoma of breast
- Malignant eccrine acrospiroma
- Inflammatory carcinoma of breast
- HER2 positive metastatic breast cancer
- Infiltrating ductal carcinoma of breast
- HER2-positive carcinoma of breast
- Primary angiosarcoma of trunk
- Primary carcinoma of breast
- Familial malignant neoplasm of ovary
- Malignant neoplasm of bone, connective tissue, skin and breast
- Secondary carcinoma of breast
- Blood/lymphatic vessel invasion by tumour absent (breast)
- Malignant neoplasm of breast in partial remission
- Malignant neoplasm of breast in full remission
- Primary angiosarcoma of breast
- Infiltrating ductal carcinoma of breast, stage 3
- Recurrent primary malignant neoplasm of breast
- Invasive ductal carcinoma of breast
- Hidradenocarcinoma
- Primary angiosarcoma of thorax
- Familial cancer of ovary
- Germline BRCA-mutated human epidermal growth factor receptor 2 negative metastatic carcinoma of breast
- Primary infiltrating ductal carcinoma of breast
- Human epidermal growth factor 2 negative carcinoma of breast
Related ICF Categories(43)
The ICF Core Set for Breast Cancer identifies functioning domains commonly assessed with this condition.
Temperament and personality functions
Energy and drive functions
Sleep functions
Emotional functions
Experience of self and time functions
Sensation of pain
Immunological system functions
Exercise tolerance functions
Weight maintenance functions
Sexual functions
Mobility of joint functions
Muscle power functions
Protective functions of the skin
Carrying out daily routine
Handling stress and other psychological demands
Changing basic body position
Maintaining body position
Walking
Washing oneself
Dressing
Looking after one's health
Doing housework
Assisting others
Basic interpersonal interactions
Complex interpersonal interactions
Intimate relationships
Acquiring, keeping and terminating a job
Remunerative employment
Community life
Recreation and leisure
Products or substances for personal consumption
Immediate family
Friends
Health professionals
Individual attitudes of immediate family members
Individual attitudes of health professionals
Societal attitudes
Housing services, systems and policies
Transportation services, systems and policies
Social security services, systems and policies
General social support services, systems and policies
Health services, systems and policies
Labour and employment services, systems and policies
Frequently Asked Questions
What is the ICD-10 code for malignant neoplasm of unsp site of unspecified female breast?
The ICD-10-CM code for malignant neoplasm of unsp site of unspecified female breast is C50.919. The full clinical description is "Malignant neoplasm of unspecified site of unspecified female breast". C50.919 is a billable/specific code that can be used on insurance claims and medical billing.
What does ICD-10 code C50.919 mean?
ICD-10-CM code C50.919 represents “Malignant neoplasm of unspecified site of unspecified female breast”. It is classified under Chapter 2: Neoplasms and is a billable/specific code that can be used on a claim.
Is C50.919 a billable code?
Yes, C50.919 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.
What chapter is C50.919 in?
C50.919 is in Chapter 2: Neoplasms (codes C00-D49).
What codes cannot be used with C50.919?
C50.919 has Excludes1 notes indicating codes that cannot be used together with it, including: skin of breast (C44.501, C44.511, C44.521, C44.591).
Are additional codes required with C50.919?
Yes, when using C50.919, also report: estrogen, and other hormones and factors receptor status (Z17.-).
What SNOMED CT codes does C50.919 map to?
C50.919 maps to 67 SNOMED CT concepts: 865954003, 403939009, 373401001, 373403003, 373402008, and 62 more. SNOMED CT is a clinical terminology used in electronic health records.
What are the UMLS CUIs for C50.919?
C50.919 is linked to 1 UMLS Concept Unique Identifier: C2842138. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.
What ICF functioning codes are related to malignant neoplasm of unsp site of unspecified female breast?
The ICF Core Set for Breast Cancer includes 43 functioning categories covering body functions, activities, and environmental factors commonly assessed with this condition. Browse the ICF directory.
What is the ICD-11 equivalent of C50.919?
There is no direct ICD-11 mapping available for C50.919 in the WHO crosswalk tables. This may mean the concept is classified differently in ICD-11. Use the ICD-10 to ICD-11 converter to search for related codes.
Automate ICD-10 Coding With AI
Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.
Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.